Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Conventional Triple Therapy for H. Pylori
NCT01418300Phase 4Completed
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lansoprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (2 arms). Primary endpoint: Eradication Rate by Urea Breath Test. Started Aug 2010; status: completed.
02
Drugs
lansoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01418300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01418300.